[1]
“THE ROLE OF ECULUZIMAB IN THE PROGNOSIS OF SHIGA TOXIN- ASSOCIATED HEMOLYTIC-UREMIC SYNDROME IN CHILDREN: A LITERATURE REVIEW”, EIC, pp. 97–106, Nov. 2025, Accessed: Jan. 24, 2026. [Online]. Available: https://periodicos.newsciencepubl.com/editoraimpacto/article/view/10222